No Cover Image

Journal article 17 views

Health and Liver Diagnostic Markers Influencing Glycemia in Subjects with Prediabetes: Preview Study

Omar Ramos-Lopez Orcid Logo, Diego Martinez-Urbistondo Orcid Logo, Santiago Navas-Carretero Orcid Logo, Ruixin Zhu, Maija Huttunen-Lenz Orcid Logo, Gareth Stratton Orcid Logo, Teodora Handjieva-Darlenska, Svetoslav Handjiev, Jouko Ensio Sundvall, Marta P. Silvestre Orcid Logo, Elli Jalo Orcid Logo, Kirsi H. Pietiläinen Orcid Logo, Tanja C. Adam, Margriet Westerterp-Plantenga Orcid Logo, Elizabeth Simpson, Ian MacDonald, Moira A. Taylor Orcid Logo, Sally D. Poppitt Orcid Logo, Wolfgang Schlicht Orcid Logo, Jennie Brand-Miller Orcid Logo, Mikael Fogelholm Orcid Logo, Anne Raben Orcid Logo, J. Alfredo Martinez

Diagnostics, Volume: 14, Issue: 24, Start page: 2895

Swansea University Author: Gareth Stratton Orcid Logo

Full text not available from this repository: check for access using links below.

Abstract

Introduction: Glucose homeostasis may be dependent on liver conditions and influence health-related markers and quality of life (QoL) objective measurements. This study aimed to analyze the interactions of glycemia with liver and health status in a prediabetic population. Subjects and methods: This...

Full description

Published in: Diagnostics
ISSN: 2075-4418
Published: MDPI AG 2024
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa68638
Abstract: Introduction: Glucose homeostasis may be dependent on liver conditions and influence health-related markers and quality of life (QoL) objective measurements. This study aimed to analyze the interactions of glycemia with liver and health status in a prediabetic population. Subjects and methods: This study included 2220 overweight/obese prediabetics from the multinational PREVIEW project. Anthropometrics; clinical, metabolic and other health-related markers; and QoL variables were analyzed. Univariate and multilinear-adjusted regression models were run to explain the interrelationships and effect modification between glycemia, health-related QoL (applying SF-12) and metabolic/liver health (using the HSI, a putative marker of fatty liver). Results: Relevant age/sex interactions were found concerning the levels of insulin, HOMA-IR, C peptide and transaminases in this prediabetic population. Multivariate models identified age, sex, glucose, WC and QoL as important predictors of HSI variability (adj. R value = 0.1393, p < 0.001), whereas the QoL status was statistically related to age, sex, HOMA-IR and HSI (adj. R value = 0.1130, p < 0.001) in this glycemia-impaired group. Furthermore, the QoL values declined with increased HSI scores, where a significant interaction was found (p = 0.011) when the data were analyzed when comparing lower glycemia vs. higher glycemia in prediabetics. Indeed, an effect modification was featured depending on the glycemia levels concerning the QoL and HSI worsening. Conclusion: Glycemia associations with the QoL status and liver metabolism markers were evidenced, with clinical implications for diabetes and liver disease precision management given the modification of the QoL outcomes depending on the liver status and glycemia concentrations. Notably, independent associations of circulating glucose with age, sex, adiposity, inflammation and C peptide levels were found.
Keywords: Prediabetes; adiposity; fatty liver; quality of life
College: Faculty of Science and Engineering
Funders: This research was supported by the EU Seventh Framework Programme (FP7; 2007–2013) (grant no. 312057), National Health and Medical Research Council (EU Collaborative Grant AUS 8, ID 1067711), Glycemic Index Foundation Australia through royalties to the University of Sydney, Health Research Council of New Zealand (grant no. 14/191), University of Auckland Faculty Research Development Fund, Cambridge Weight Plan, Danish Agriculture and Food Council, Danish Meat Research Institute, National Institute for Health Research Biomedical Research Centre (NIHR BRC) (UK), Biotechnology and Biological Sciences Research Council (BBSRC) (UK), Engineering and Physical Sciences Research Council (EPSRC) (UK), Nutritics (Dublin), Juho Vainio Foundation (Finland), Academy of Finland (grants no. 272376, 314383, 266286 and 314135), Finnish Medical Foundation, Gyllenberg Foundation (Finland), Novo Nordisk Foundation, Finnish Diabetes Research Foundation, University of Helsinki, Government Research Funds for Helsinki University Hospital, Jenny and Antti Wihuri Foundation (Finland), Emil Aaltonen Foundation (Finland) and China Scholarship Council.
Issue: 24
Start Page: 2895